Jakob M. Goldmann

Jakob M. Goldmann

Auto-generated profile, based on publicly available information

Jakob M. Goldmann

Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2015 in Science
Verified
Journal Article
Closed access
PDF file
MMMarta Melé
Marta Melé
Pedro G. FerreiraPedro G. Ferreira
Pedro G. Ferreira
FRFerran Reverter
Ferran Reverter
DDDavid S. DeLuca
David S. DeLuca
JMJean Monlong
Jean Monlong
Roderic Guigó SerraRoderic Guigó Serra
Roderic Guigó Serra
Expression, genetic variation, and tissues: Human genomes show extensive genetic variation across individuals, but we have only just started documenting the effects of this variation on the regulation of gene expression. Furthermore, only a few tissues have been examined per genetic variant. In order to examine how genetic expression varies among tissues within individuals, the Genotype-Tissue Expression (GTEx) Consortium collected 1641 postmortem samples covering 54 body sites from 175 individuals. They identified quantitative genetic traits that affect gene expression and determined which of these exhibit tissue-specific expression patterns. Meléet al.measured how transcription varies among tissues, and Rivaset al.looked at how truncated protein variants affect expression across tissues.Science, this issue p.648, p.660, p.666; see also p.640

20 June 2016 in Nature Genetics
Verified
Journal Article
Closed access
JGJakob M Goldmann
Jakob M Goldmann
WWWendy S W Wong
Wendy S W Wong
MPMichele Pinelli
Michele Pinelli
TFTerry Farrah
Terry Farrah
DBDale Bodian
Dale Bodian
JNJohn E Niederhuber
John E Niederhuber

1 November 2019 in Trends in Genetics
Verified
Journal Article
Open access
JGJ.M. Goldmann
J.M. Goldmann
JVJ.A. Veltman
J.A. Veltman
CGChristian Gilissen
Christian Gilissen
Human germline de novo mutations (DNMs) are both a driver of evolution and an important cause of genetic diseases. In the past few years, whole-genome sequencing (WGS) of parent-offspring trios has facilitated the large-scale detection and study of human DNMs, which has led to exciting discoveries. The overarching theme of all of these studies is that the DNMs of an individual are a complex mixture of mutations that arise through different biological processes acting at different times during human development and life.

5 March 2018 in Nature Genetics
Verified
Journal Article
Closed access
JGJakob M. Goldmann
Jakob M. Goldmann
VSVladimir B. Seplyarskiy
Vladimir B. Seplyarskiy
WWWendy S. W. Wong
Wendy S. W. Wong
TVThierry Vilboux
Thierry Vilboux
PNPieter B. Neerincx
Pieter B. Neerincx
JNJohn E. Niederhuber
John E. Niederhuber

27 August 2021 in Science
Verified
Journal Article
Closed access
VSVladimir B. Seplyarskiy
Vladimir B. Seplyarskiy
RSRuslan A. Soldatov
Ruslan A. Soldatov
EKEvan Koch
Evan Koch
RMRyan J. McGinty
Ryan J. McGinty
JGJakob M. Goldmann
Jakob M. Goldmann
SSShamil Sunyaev
Shamil Sunyaev
Gauging the spectrum of human mutations: It has become increasing clear that mutation affects phenotypic variation and disease risk across humans. However, there are many different types of mutation. Seplyarskiy et al . applied a matrix factorization method to large human genomic datasets to identify germline mutational processes in an unsupervised manner. From this survey, nine robust mutational components were identified and specific mechanisms generating seven of these processes are proposed from correlations with genomic features. These results confirm and improve upon our understanding of mutational processes and reveal likely mechanisms of mutation in the human genome. —LMZ

2 October 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MHManuel Holtgrewe
Manuel Holtgrewe
AKAlexej Knaus
Alexej Knaus
GHGabriele Hildebrand
Gabriele Hildebrand
JPJean-Tori Pantel
Jean-Tori Pantel
MSMiguel Rodriguez de Los Santos
Miguel Rodriguez de Los Santos
PKPeter Michael Krawitz
Peter Michael Krawitz
A genome-wide evaluation of the effects of ionizing radiation on mutation induction in the mouse germline has identified multisite de novo mutations (MSDNs) as marker for previous exposure. Here we present the results of a small pilot study of whole genome sequencing in offspring of soldiers who served in radar units on weapon systems that were emitting high-frequency radiation. We found cases of exceptionally high MSDN rates as well as an increased mean in our cohort: While a MSDN mutation is detected in average in 1 out of 5 offspring of unexposed controls, we observed 12 MSDNs in altogether 18 offspring, including a family with 6 MSDNs in 3 offspring. Moreover, we found two translocations, also resulting from neighboring mutations. Our findings indicate that MSDNs might be suited in principle for the assessment of DNA damage from ionizing radiation also in humans. However, as exact person-related dose values in risk groups are usually not available, the interpretation of MSDNs in single families would benefit from larger molecular epidemiologic studies on this new biomarker.